Analyst Ratings for Integra LifeSciences (IART) [Neutrals]
IART Rating Summary
IART Price Target Summary
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$41.86 (+14.3%)
Avg. $ Target:
$41.86 (+14.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/11/2013 | Janney Montgomery Scott | Downgrade | Neutral (Buy) |
35.00 (52.00) |
38.38 | 36.62 | -4.59% | Details |
| 4/11/2013 | Northland Securities | Downgrade | Market Perform (Outperform) |
43.00 (N/A) |
38.38 | 36.62 | -4.59% | Details |
| 11/16/2012 | SunTrust Robinson Humphrey | New Coverage | Neutral (N/A) |
33.00 (N/A) |
36.56 | 36.62 | 0.16% | Details |
| 10/12/2012 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
39.07 | 36.62 | -6.27% | Details |
| 8/18/2011 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
39.61 | 36.62 | -7.55% | Details |
| 1/24/2011 | RBC Capital | Downgrade | Sector Perform (N/A) |
N/A (N/A) |
48.00 | 36.62 | -23.71% | Details |
| 1/20/2011 | Northcoast Research | New Coverage | Neutral (N/A) |
N/A (N/A) |
48.48 | 36.62 | -24.46% | Details |
| 1/3/2011 | JPMorgan | Downgrade | Neutral (N/A) |
N/A (N/A) |
47.30 | 36.62 | -22.58% | Details |
| 9/10/2010 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
37.50 | 36.62 | -2.35% | Details |
